Validity and Reliability of the Dutch HDI
Launched by UNIVERSITY GHENT · Nov 15, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a questionnaire called the Dutch Henry Ford Hospital Headache Disability Questionnaire (HDI) to see how well it works for patients with headaches and neck pain. The goal is to determine if this questionnaire accurately measures how headaches affect people’s daily lives. The researchers are currently looking for participants to join the study.
To be eligible, you need to be between the ages of 65 and 74 and must have been diagnosed with a type of headache by a neurologist. This includes both primary headaches (like migraines) and secondary headaches (which can be caused by other conditions). Participants should have had at least one day of headache in the last month and must speak Dutch. However, individuals with certain serious medical issues or specific types of headaches not recognized by neurology guidelines cannot participate. If you join, you’ll help improve understanding and treatment options for headache disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with primary or secondary headache, diagnosed by a neurologist according to the ICHD-3 classification.
- • At least 1 day of headache in the previous month.
- • Native Dutch speaking participants
- Exclusion Criteria:
- • All other headache types not classified by the ICHD-3 as primary or secondary headache.
- • Secondary headache in combination with underlying pathological situations (infection, trauma, tumors, brain haemorrhages) or severe psychotic or mental dysfunctions or substance use/withdrawal symptoms.
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, Oost Vlaanderen, Belgium
Ghent, , Belgium
Patients applied
Trial Officials
Barbara Cagnie, Prof. Dr.
Principal Investigator
University Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials